Esta web utiliza cookies para que podamos ofrecerte la mejor experiencia de usuario posible. La información de las cookies se almacena en tu navegador y realiza funciones tales como reconocerte cuando vuelves a nuestra web o ayudar a nuestro equipo a comprender qué secciones de la web encuentras más interesantes y útiles.
Navas S,Carreño V. J Hepatol 1995; 22: s115-s117.
Ribozymes: structure, characteristics and use as potential antiviral agents
Bartolomé J, Madejón A,Carreño V. J Hepatol 1995; 22: s57-s64.
Hepatitis B and D genomes in hepatitis B surface antigen negative patients with chronic hepatitis C
González S, Navas S, Madejón A, Bartolomé J, Castillo I, Moraleda G, Martín J, Marriott E, Herrero M,Carreño V. J Med Virol 1995; 45: 168-173.
Sequence of non-structural regions 3 and 5 of hepatitis C virus genomes from Spanish patients: existence of a predominant variant related to type 1b
Pernas M, Bartolomé J, Castillo I, Quiroga JA, Pardo M,Carreño V.J Gen Virol 1995; 76: 415-420.
Immunoglobulin M antibody to hepatitis C virus core antigen: Correlations with viral replication, histological activity and liver disease outcome.
Quiroga JA, van Binsbergen J, Wang CY, Pardo M, Navas S, Trines Ch, Herrero M,Carreño V. Hepatology 1995; 22: 1635-1640.
Serum levels of soluble immune factors and pathogenesis of chronic hepatitis C, and their relation to therapeutic response to alpha-interferon
Quiroga JA, Martín J, Pardo M,Carreño V. Dig Dis Sci 1994; 39: 2485-2496.
Evidence of Subtype-Specific Antibodies to Antigenic Epitopes in the NS5 Region of Hepatitis C Virus in the Circulation of Patients with Chronic Hepatitis C
Quiroga JA, Martín J, Pernas M, Pardo M, Herrero M, Castillo I, Bartolomé J,Carreño V. Clin Diag Lab Immunol 1994; 1: 545-551.
Comparison of several PCR procedures for detection of HCV RNA using different regions of the HCV genome
Castillo I, Bartolomé J, Quiroga JA,Carreño V. J Virol Methods 1992; 38: 71-80.
Protein composition of hepatitis B virus e antigen in the natural course of the disease and following interferon therapy.
Campillo ML, Quiroga JA, Bartolomé J, Moraleda G, Castillo I,Carreño V. J Clin Microbiol 1992; 30: 1256-1261.
Analysis of serum pre-S antigens in chronic hepatitis B virus infection in relation to the expression pattern of hepatitis B virus DNA in the liver.
Escudero MM, Quiroga JA, Bartolomé J,Carreño V. Digestion 1991; 49: 204-211.
Different levels of hepatitis B virus replication among hepatitis B e antigen positive chronic carriers.
Bartolomé J, Castillo I, Mora I, Gutiez J, Porres JC,Carreño V. Acta Virol 1988; 32: 193-197.
Detección del anticuerpo de clase IgM contra el antígeno del core del virus B de la hepatitis en pacientes con infección crónica.
Quiroga JA, Bartolomé J,Carreño V, Mora I, Porres JC, Gutiez J, Hernández-Guío C. Rev Clin Esp 1987; 181: 351-354.